共 50 条
- [5] ERα36 is an effective target of epigallocatechin-3-gallate in hepatocellular carcinoma [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (09): : 3222 - 3234
- [8] Renal outcomes with dipeptidyl peptidase-4 inhibitors [J]. DIABETES & METABOLISM, 2018, 44 (02) : 101 - 111
- [10] Cardiovascular effects of dipeptidyl peptidase-4 inhibitors [J]. HIPPOKRATIA, 2015, 19 (03) : 195 - 199